$269 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 50 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 73.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VCYT | Buy | VERACYTE INC | $27,192,000 | +13.6% | 3,513,161 | +11.7% | 10.11% | +12.5% |
| LBIO | Buy | LION BIOTECHNOLOGIES INC | $26,479,000 | -0.4% | 3,809,944 | +18.0% | 9.85% | -1.3% |
| IRIX | Buy | IRIDEX CORP | $21,851,000 | +23.5% | 1,554,146 | +27.3% | 8.13% | +22.4% |
| IMMU | Buy | IMMUNOMEDICS INC | $17,249,000 | +37.8% | 4,700,000 | +22.1% | 6.41% | +36.5% |
| Buy | NEURODERM LTD | $14,784,000 | +72.7% | 665,944 | +43.8% | 5.50% | +71.1% | |
| EDGE | Buy | EDGE THERAPEUTICS INC | $13,003,000 | +77.7% | 1,040,265 | +48.0% | 4.84% | +75.9% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $11,866,000 | +423.9% | 976,599 | +210.8% | 4.41% | +419.2% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $11,644,000 | +59.6% | 575,309 | +58.5% | 4.33% | +58.1% |
| Buy | IMMUNOMEDICS INCnote 4.750% 2/1 | $10,395,000 | +64.1% | 10,500,000 | +40.0% | 3.87% | +62.6% | |
| ACRS | New | ACLARIS THERAPEUTICS INC | $10,117,000 | – | 372,753 | +100.0% | 3.76% | – |
| IWM | Buy | ISHARES TRput | $9,440,000 | +90.0% | 70,000 | +75.0% | 3.51% | +88.2% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $8,652,000 | +23.6% | 300,000 | +36.4% | 3.22% | +22.4% |
| CEMI | Buy | CHEMBIO DIAGNOSTICS INC | $7,826,000 | +37.1% | 1,150,925 | +49.1% | 2.91% | +35.7% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $7,275,000 | +14.8% | 698,825 | -0.2% | 2.70% | +13.7% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $7,039,000 | +37.4% | 470,834 | +15.5% | 2.62% | +36.1% |
| MRVL | Sell | MARVELL TECHNOLOGY GROUP LTDord | $6,935,000 | +2.5% | 500,000 | -2.0% | 2.58% | +1.5% |
| CASM | Buy | CAS MED SYS INC | $6,730,000 | +1.2% | 4,179,838 | +8.7% | 2.50% | +0.3% |
| RARX | New | RA PHARMACEUTICALS INC | $5,740,000 | – | 377,909 | +100.0% | 2.13% | – |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $4,470,000 | -18.8% | 40,000 | -3.6% | 1.66% | -19.6% |
| NBRV | Buy | NABRIVA THERAPEUTICS AGsponsored adr | $4,210,000 | +2.3% | 706,383 | +21.1% | 1.57% | +1.4% |
| WBMD | Sell | WEBMD HEALTH CORP | $3,966,000 | -16.0% | 80,000 | -15.8% | 1.48% | -16.8% |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $3,228,000 | +57.9% | 91,898 | +63.3% | 1.20% | +56.5% |
| VCYT | New | VERACYTE INCcall | $2,903,000 | – | 375,000 | +100.0% | 1.08% | – |
| DERM | Sell | DERMIRA INC | $2,684,000 | -25.8% | 88,500 | -17.3% | 1.00% | -26.6% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $2,593,000 | -36.6% | 162,600 | -33.9% | 0.96% | -37.3% |
| REPH | New | RECRO PHARMA INC | $2,418,000 | – | 300,000 | +100.0% | 0.90% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $2,100,000 | – | 1,000,000 | +100.0% | 0.78% | – |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $1,893,000 | -82.1% | 50,000 | -82.1% | 0.70% | -82.3% |
| CLSD | New | CLEARSIDE BIOMEDICAL INC | $1,565,000 | – | 175,000 | +100.0% | 0.58% | – |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $1,548,000 | – | 15,000 | +100.0% | 0.58% | – |
| SRPT | New | SAREPTA THERAPEUTICS INCput | $1,372,000 | – | 50,000 | +100.0% | 0.51% | – |
| Buy | ESSA PHARMA INC | $1,330,000 | -20.7% | 605,300 | +3.2% | 0.50% | -21.4% | |
| EXEL | New | EXELIXIS INCput | $1,193,000 | – | 80,000 | +100.0% | 0.44% | – |
| ALIM | ALIMERA SCIENCES INC | $1,052,000 | -27.5% | 974,318 | 0.0% | 0.39% | -28.3% | |
| LBIO | New | LION BIOTECHNOLOGIES INCcall | $1,043,000 | – | 150,000 | +100.0% | 0.39% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $950,000 | -61.1% | 150,000 | -72.9% | 0.35% | -61.5% |
| RMTI | New | ROCKWELL MED INCput | $917,000 | – | 140,000 | +100.0% | 0.34% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $722,000 | -85.4% | 145,300 | -78.3% | 0.27% | -85.6% |
| SPNC | New | SPECTRANETICS CORP | $674,000 | – | 27,500 | +100.0% | 0.25% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALScall | $627,000 | +32.6% | 99,000 | -7.6% | 0.23% | +30.9% |
| ARDX | Buy | ARDELYX INC | $382,000 | +13.4% | 26,891 | +3.1% | 0.14% | +11.8% |
| IMMU | Buy | IMMUNOMEDICS INCcall | $367,000 | +93.2% | 100,000 | +70.6% | 0.14% | +91.5% |
| ASMB | New | ASSEMBLY BIOSCIENCES INCcall | $122,000 | – | 10,000 | +100.0% | 0.04% | – |
| ONS | Sell | ONCOBIOLOGICS INC | $88,000 | -91.6% | 29,082 | -88.1% | 0.03% | -91.6% |
| New | ENDOLOGIX INCnote 2.250%12/1 | $86,000 | – | 96,000 | +100.0% | 0.03% | – | |
| ONSIZ | ONCOBIOLOGICS INC*w exp 05/18/201 | $76,000 | -21.6% | 96,833 | 0.0% | 0.03% | -22.2% | |
| MNKD | MANNKIND CORPput | $58,000 | +3.6% | 90,000 | 0.0% | 0.02% | +4.8% | |
| PSTI | New | PLURISTEM THERAPEUTICS INCput | $30,000 | – | 21,100 | +100.0% | 0.01% | – |
| ONSIW | ONCOBIOLOGICS INC*w exp 02/18/201 | $18,000 | -61.7% | 96,833 | 0.0% | 0.01% | -61.1% | |
| OHRP | New | OHR PHARMACEUTICAL INCcall | $15,000 | – | 10,000 | +100.0% | 0.01% | – |
| PTX | Exit | PERNIX THERAPEUTICS HLDGS INput | $0 | – | -73,500 | -100.0% | -0.02% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INCput | $0 | – | -11,900 | -100.0% | -0.02% | – |
| AGTC | Exit | APPLIED GENETIC TECHNOL CORP | $0 | – | -10,193 | -100.0% | -0.04% | – |
| CBMX | Exit | COMBIMATRIX CORPORATION | $0 | – | -47,431 | -100.0% | -0.05% | – |
| AKTX | Exit | AKARI THERAPEUTICS PLCsponsored adr | $0 | – | -23,169 | -100.0% | -0.07% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALSput | $0 | – | -50,600 | -100.0% | -0.08% | – |
| DXTRQ | Exit | DEXTERA SURGICAL INC | $0 | – | -128,958 | -100.0% | -0.09% | – |
| PGNX | Exit | PROGENICS PHARMACEUTICALS INcall | $0 | – | -40,000 | -100.0% | -0.10% | – |
| TROV | Exit | TROVAGENE INCput | $0 | – | -80,000 | -100.0% | -0.14% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.14% | – |
| CRBP | Exit | CORBUS PHARMACEUTICALS HLDGS | $0 | – | -81,302 | -100.0% | -0.21% | – |
| EHIC | Exit | EHI CAR SVCS LTDspon ads cl a | $0 | – | -58,827 | -100.0% | -0.23% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -32,809 | -100.0% | -0.28% | – |
| AGEN | Exit | AGENUS INC | $0 | – | -104,178 | -100.0% | -0.28% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -0.31% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -30,000 | -100.0% | -0.37% | – |
| ATRC | Exit | ATRICURE INC | $0 | – | -66,186 | -100.0% | -0.39% | – |
| SVA | Exit | SINOVAC BIOTECH LTD | $0 | – | -204,358 | -100.0% | -0.45% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -40,000 | -100.0% | -0.48% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.50% | – |
| ALR | Exit | ALERE INC | $0 | – | -45,000 | -100.0% | -0.73% | – |
| GHDX | Exit | GENOMIC HEALTH INC | $0 | – | -72,100 | -100.0% | -0.78% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -40,000 | -100.0% | -0.81% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INCcall | $0 | – | -59,600 | -100.0% | -0.84% | – |
| TSRO | Exit | TESARO INC | $0 | – | -22,700 | -100.0% | -0.85% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -39,700 | -100.0% | -0.92% | – |
| PGNX | Exit | PROGENICS PHARMACEUTICALS IN | $0 | – | -432,370 | -100.0% | -1.03% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -30,000 | -100.0% | -1.04% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -1.15% | – |
| INNL | Exit | INNOCOLL HLDGS PLC | $0 | – | -671,517 | -100.0% | -1.46% | – |
| CEMP | Exit | CEMPRA INC | $0 | – | -210,000 | -100.0% | -1.91% | – |
| XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -150,000 | -100.0% | -3.73% | – |
| EVDY | Exit | EVERYDAY HEALTH INC | $0 | – | -1,550,000 | -100.0% | -4.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.